IDS Holdings PLC is an internationally active company in the medical technology industry. The company specializes in the development and manufacture of innovative diagnostic products in the areas of autoimmunity, endocrinology, cancer, and infectious diseases. IDS is divided into two core areas: immunoassays and fully automated analysis systems. In the immunoassays sector, the company offers a wide portfolio of high-quality diagnostic test kits for measuring hormones, tumor markers, and other biomarkers. The product range includes ELISA kits, RIA kits, IFA kits, and CLIA kits. IDS is also a leading provider of fully automated analysis systems, which are used by laboratories to bring testing to a new level of efficiency and precision. IDS-iSYS includes a wide range of systems for immunoassay and hormone testing, as well as testing for infectious diseases and drug abuse. IDS aims to simplify laboratory diagnostics by delivering automation, simplicity, and reliability. The company is headquartered in the UK and has branches and sales offices in Europe, North America, and Asia. IDS collaborates with leading medical institutions and continuously develops innovative products to meet the demand for diagnostic solutions. IDS has established itself as a reliable provider of accurate, fast, and affordable diagnostic products. The company also has a strong presence in emerging markets such as Asia and Latin America. IDS' focus remains on expanding its product range while providing advanced diagnosis tools to make medical testing a more effective and efficient process. Over the years, IDS has received numerous awards and recognition, including the Queen's Award for Innovation and the Best European Company of the Year award at the Medilink UK Business Awards. These awards reflect the high quality and innovative spirit that are at the core of the company's business model. In summary, IDS is a company specializing in the development and manufacture of diagnostics to meet the requirements of medical diagnostics. The company serves various application areas including autoimmunity, endocrinology, cancer, and infectious diseases. IDS offers a wide range of diagnostic test kits such as ELISA kits, RIA kits, IFA kits, and CLIA kits, as well as fully automated analysis systems. IDS is a reliable provider of accurate, fast, and affordable diagnostic products and has a strong presence in emerging markets. The company continuously strives to expand its product range and provide advanced diagnosis tools to make medical testing a more effective and efficient process.
خطة التوفير Scalable Capital
خطة التقسيط من Trade Republic
comdirect خطة الادخار
خطة التوفير في Consorsbank
خطة التوفير ING
